1. Home
  2. AVT vs MIRM Comparison

AVT vs MIRM Comparison

Compare AVT & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avnet Inc.

AVT

Avnet Inc.

HOLD

Current Price

$88.19

Market Cap

8.0B

Sector

Technology

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$82.85

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVT
MIRM
Founded
1921
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.2B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
AVT
MIRM
Price
$88.19
$82.85
Analyst Decision
Hold
Strong Buy
Analyst Count
4
14
Target Price
$106.25
★ $153.07
AVG Volume (30 Days)
★ 1.1M
732.8K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
★ 1.59%
N/A
EPS Growth
45.82
★ 74.59
EPS
★ 4.01
N/A
Revenue
★ $27,632,683,000.00
$19,138,000.00
Revenue This Year
$34.12
$33.62
Revenue Next Year
$5.84
$17.72
P/E Ratio
$23.17
★ N/A
Revenue Growth
★ 24.47
N/A
52 Week Low
$44.25
$63.23
52 Week High
$108.63
$130.00

Technical Indicators

Market Signals
Indicator
AVT
MIRM
Relative Strength Index (RSI) 37.23 43.78
Support Level $82.88 $78.07
Resistance Level $89.21 $88.31
Average True Range (ATR) 3.19 3.94
MACD -1.53 0.72
Stochastic Oscillator 11.25 50.24

Price Performance

Historical Comparison
AVT
MIRM

About AVT Avnet Inc.

Avnet Inc is an electronic component technology distributor and solutions provider serving customers across the Americas, EMEA, and Asia. It works with electronic component manufacturers in every electronic component segment and serves startups, mid-sized businesses, enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). Its segments are Electronic Components (EC) and Farnell, with EC generating maximum revenue. The EC operating group mainly supports high- and medium-volume customers and markets, and sells and distributes semiconductors, IP&E components (interconnect, passive, and electromechanical components), and other integrated and embedded components.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: